Which hemodynamic finding is consistent with cardiogenic shock as defined in this presentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hemodynamic Findings Consistent with Cardiogenic Shock

All four options listed represent hemodynamic findings consistent with cardiogenic shock, but the most definitive diagnostic criteria require BOTH systolic BP <90 mm Hg for >30 minutes AND cardiac index <2.2 L/min/m² (or <1.8 L/min/m² without support) combined with PCWP >15 mm Hg. 1

Core Hemodynamic Diagnostic Criteria

The 2022 AHA/ACC/HFSA guidelines establish that cardiogenic shock diagnosis requires meeting all three core hemodynamic parameters simultaneously when invasive monitoring is available 1, 2:

  • Cardiac index <2.2 L/min/m² (severe dysfunction defined as <1.8 L/min/m² without vasopressor/inotropic support) 1, 2, 3
  • Pulmonary capillary wedge pressure (PCWP) >15 mm Hg (often >18-20 mm Hg in classic presentations) 1, 2, 3, 4
  • **Systolic blood pressure <90 mm Hg** sustained for >30 minutes OR requiring vasopressors to maintain SBP ≥90 mm Hg 1, 2

Analysis of Each Option

PCWP >15 mm Hg

This is a required hemodynamic criterion for cardiogenic shock. Elevated PCWP reflects left ventricular failure with backward transmission of pressure into the pulmonary circulation, distinguishing cardiogenic shock from hypovolemic shock (where PCWP would be low) 1, 5, 2. The failing myocardium cannot generate adequate output despite these elevated filling pressures 5.

Cardiac Index <1.8 L/min/m² Without Support

This represents severe cardiogenic shock and is the most specific hemodynamic marker. The threshold of <1.8 L/min/m² without vasopressor or inotropic support defines profound cardiac dysfunction 1, 2. The European Society of Cardiology specifically identifies CI <1.8 L/min/m² with central filling pressure >20 mm Hg as severe cardiac dysfunction 5. This parameter, when combined with elevated PCWP, confirms the diagnosis 4, 6.

Systolic BP of 130 mm Hg

This finding is INCONSISTENT with cardiogenic shock. The diagnostic criteria explicitly require SBP <90 mm Hg sustained for >30 minutes or the need for vasopressors to maintain SBP ≥90 mm Hg 1, 2. A systolic pressure of 130 mm Hg would place the patient in SCAI Stage A (at-risk) at most, with normal hemodynamics 1, 7.

Systolic BP <90 mm Hg for >30 Minutes

This is a required clinical criterion for cardiogenic shock diagnosis. However, hypotension alone is insufficient—it must be accompanied by evidence of end-organ hypoperfusion (decreased mentation, cold extremities, urine output <30 mL/h, lactate >2 mmol/L) AND the hemodynamic parameters above 1, 2. This represents SCAI Stage C (classic cardiogenic shock) when combined with hypoperfusion and elevated filling pressures 1, 7.

Critical Diagnostic Algorithm

When evaluating suspected cardiogenic shock, follow this sequence 1, 2:

  1. Confirm sustained hypotension: SBP <90 mm Hg for >30 minutes OR MAP <60 mm Hg OR vasopressor requirement 1, 2

  2. Document end-organ hypoperfusion (at least one required) 1, 2:

    • Altered mental status
    • Cold extremities with livedo reticularis
    • Urine output <30 mL/hour
    • Lactate >2 mmol/L
  3. Obtain invasive hemodynamics via pulmonary artery catheter 1, 6:

    • Cardiac index <2.2 L/min/m²
    • PCWP >15 mm Hg
    • Calculate cardiac power output: (CO × MAP) ÷ 451; if <0.6 W, this indicates refractory shock requiring mechanical circulatory support 1, 2

Common Pitfalls to Avoid

Do not diagnose cardiogenic shock based on hypotension alone. Both hypotension AND clinical evidence of hypoperfusion must be present simultaneously 1, 2. A patient with SBP <90 mm Hg but warm extremities, normal mentation, and adequate urine output represents SCAI Stage B (beginning shock), not classic cardiogenic shock 1, 7.

Distinguish cardiogenic from other shock types using filling pressures. Cardiogenic shock uniquely presents with elevated PCWP (>15 mm Hg) and elevated CVP, whereas hypovolemic shock shows low filling pressures and distributive shock shows low systemic vascular resistance with normal or increased cardiac output initially 5, 2.

Recognize that a systolic BP of 130 mm Hg excludes the diagnosis of cardiogenic shock regardless of other parameters, as the blood pressure criterion is absolute 1, 2.

Related Questions

In a 50-year-old man with a history of heart failure presenting with acute pulmonary edema, tachypnea, tachycardia, hypoxemia (PaO₂ 60 mm Hg) and hypercapnia (PaCO₂ 48 mm Hg) while receiving 2 L/min nasal cannula oxygen, what is the most appropriate next step in management?
Can acute heart failure (Killip class II–IV) with evidence of low cardiac output or risk of cardiogenic shock be diagnosed without an echocardiogram?
What is the initial management for a patient with acute pulmonary edema presenting with basal crackles, oxygen saturation of 89%, lower‑extremity edema, and a concurrent initial diagnosis of sepsis?
What is the difference between pulmonary edema and congestive heart failure (CHF) in terms of management and treatment?
How to manage a 55-year-old patient with unrecordable blood pressure (hypotension), feeble pulse, and pulmonary edema, weighing 60 kilograms (kg)?
Are blurry vision, left‑sided abdominal sharp pain, and sudden acid reflux on cycle day 22 (8 days post‑ovulation after embryo transfer) typical implantation symptoms?
What is the recommended dosing regimen for mycophenolate mofetil in an adult with rheumatoid arthritis‑associated interstitial lung disease, including adjustments for low body weight, impaired renal function, side‑effect tolerance, monitoring schedule, infection prophylaxis, and alternative therapies?
Are antibiotics recommended for patients with an open chest after cardiac surgery (delayed sternal closure)?
How do Voltaren (diclofenac) and ibuprofen differ in potency, dosing, formulations, and safety risks?
What renal cortical thickness measurements on ultrasound indicate the severity of chronic kidney disease in adults?
Why is altered mental status a contraindication to continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.